[Initial results of a combined adriamycin, solcoseryl (actihaemyl) and vincristine therapy].
D000183:Actihaemyl / Q000008:administration & dosage* / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000188:drug therapy; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004407:Dysgerminoma / Q000188:drug therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D012075:Remission, Spontaneous; D012509:Sarcoma / Q000188:drug therapy; D014020:Tissue Extracts / Q000008:administration & dosage*; D014750:Vincristine / Q000008:administration & dosage* / Q000627:therapeutic use
D014020:Tissue Extracts; D000183:Actihaemyl; D014750:Vincristine; D004317:Doxorubicin
Erste Ergebniss einer kombinierten Anwendung von Adriamycin, Solcoseryl (Actihaemyl) und Vincristin